21 CFR Part 211 details the current good manufacture practice for finished pharmaceuticals ... identity of the component as labeled prior to release for use in drug product manufacturing. The ...

Revised guidelines propose major improvements in physical infrastructure, air handling units and equipment and machinery.

The new Schedule M will be implemented from 1 January, 2026, to help MSMEs adjust to updated manufacturing standards.

Union Health Ministry extends deadline for pharmaceutical firms to comply with revised Schedule M standards by December 31, ...

In a groundbreaking advancement toward cell therapy and regenerative medicine, the Abu Dhabi Stem Cells Center (ADSCC) has ...

The Abu Dhabi Stem Cells Center (ADSCC) in the UAE has developed clinical-grade induced pluripotent stem cells (iPSCs) that ...

a leading European-based Good Manufacturing Practice (GMP) manufacturer. This collaboration will supply Clinical Trial Material (CTM) for Polyrizon’s PL-14 allergy blocker, in preparation for a ...

CDSCO aims to eliminate spurious medicines by implementing stricter GMP compliance and risk-based inspections.

These companies now have until December 31, 2025, to comply with the improved manufacturing practices. The extension comes following requests from manufacturing units to upgrade their facilities, the ...